NCT00909636View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2009

Conditions
HCV Infection
Interventions
DRUG

ABT-333

See arm description for more information

DRUG

Placebo

See arm description for more information

Trial Locations (1)

60085

Site Reference ID/Investigator# 20081, Waukegan

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00909636 - A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet | Biotech Hunter | Biotech Hunter